Lv71
4810 积分 2021-12-06 加入
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
23分钟前
待确认
Cancer vaccines and the future of immunotherapy
18天前
已完结
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
21天前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 stud
24天前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 stud
24天前
已完结
IL-10-expressinganti-CD19CARTcellsforpatientswithrelapsedorrefractoryB-cellacutelymphoblasticleukaemia:anopen-labelsingle-armphase1study
24天前
已关闭
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
1个月前
已完结
CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia
1个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
2个月前
已完结
CAR-T Rapid Manufacturing: Implications on Product and Analytical Testing
2个月前
已完结
Interview with Carlos Caldas
皖公网安备34019202002308
